The role of neoadjuvant chemotherapy for invasive bladder cancer
Open Access
- 1 July 1998
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 82 (1) , 33-42
- https://doi.org/10.1046/j.1464-410x.1998.00674.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapyCancer, 1994
- Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostateCancer, 1994
- Neoadjuvant and classic adjuvant chemotherapy for bladder cancerCurrent Opinion in Urology, 1991
- Bladder cancer: Long-term follow-up results of patients treated with radical radiationClinical Oncology, 1991
- The Role of Adjuvant Chemotherapy Following Cystectomy for Invasive Bladder Cancer: A Prospective Comparative TrialJournal of Urology, 1991
- Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.Journal of Clinical Oncology, 1990
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985
- Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1985
- Cis‐diamminedichloroplatinum (DDP) as Initial Treatment of lnvasive Bladder CancerBritish Journal of Urology, 1984
- Bladder carcinoma as a systemic diseaseCancer, 1979